Verification of the minimal clinically important difference of the Capabilities of Upper Extremity Test in patients with subacute spinal cord injury.
J Spinal Cord Med
; : 1-8, 2023 Nov 06.
Article
em En
| MEDLINE
| ID: mdl-37930635
ABSTRACT
CONTEXT The number of patients with cervical spinal cord injury (CSCI) is increasing, and the Capabilities of Upper Extremity Test (CUE-T) is recommended for introduction in clinical trials. We calculated the minimal clinically important difference (MCID) of the CUE-T using an adjustment model with an interval of 1 month. DESIGN:
This was a prospective study.SETTING:
This study was conducted with participants from the Chiba Rehabilitation Center in Japan.PARTICIPANTS:
The participants were patients with subacute CSCI.INTERVENTIONS:
The CUE-T and spinal cord independence measure (SCIM) III were performed twice within an interval of 1 month. OUTCOMEMEASURES:
The MCID was calculated using an adjustment model based on logistic regression analysis. The participants were classified into an improvement group and a non-improvement group based on the amount of change in the two evaluations using the 10-point SCIM III MCID as an anchor.RESULTS:
There were 52 participants (56.8 ± 13.5 years old, 45 men/7 women) with complete or incomplete CSCI 18 in the improvement group and 34 in the non-improvement group. A significant regression equation was obtained when calculating the MCID, and the total, hand, and side scores were 7.7, 2.0, and 3.7 points, respectively.CONCLUSION:
The calculated MCID of the CUE-T in this study was 7.7 points. The results of this study provide useful criteria for implementation in clinical trials. Future studies should use patient-reported outcomes, a more recommended anchor, and calculate the MCID using methods such as the patient's condition.
Texto completo:
1
Coleções:
01-internacional
Base de dados:
MEDLINE
Idioma:
En
Ano de publicação:
2023
Tipo de documento:
Article